Percutaneous penetration via hand eczema is the major accelerating factor for systemic absorption of toluene and xylene during car spray painting

Contact Dermatitis

Volumn 58, Issue 2, 2008, Pages 76-79

  Hino, Ryosuke ^a   Nishio, Daisuke ^a   Kabashima, Kenji ^a   Tokura, Yoshiki ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Hand eczema; Hippuric acid; Methylhippuric acid; Toluene; Xylene

Indexed keywords

HIPPURIC ACID; METHYLHIPPURIC ACID; ORGANIC SOLVENT; TOLUENE; UNCLASSIFIED DRUG; XYLENE;

ADULT; ARTICLE; CAR SPRAY PAINTING; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG ABSORPTION; DRUG PENETRATION; HAND ECZEMA; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PAINTING; RESPIRATORY TRACT DISEASE; STATISTICAL SIGNIFICANCE; URINARY EXCRETION;

AUTOMOBILES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ECZEMA; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HIPPURATES; HUMANS; MALE; OCCUPATIONAL EXPOSURE; PAINT; SEVERITY OF ILLNESS INDEX; SKIN ABSORPTION; SOLVENTS; STATISTICS, NONPARAMETRIC; TOLUENE; XYLENES;

EID: 38049004288     PISSN: 01051873     EISSN: 16000536     Source Type: Journal    
DOI: 10.1111/j.1600-0536.2007.01265.x     Document Type: Article

References (14)

1. Elofsson S, Gambarale F, Hindmarsh T et al. Exposure to organic solvents. Scand J Work Environ Health 1980 : 6 : 239 273.
2. Husman K. Symptoms of car painters with long exposure to mixture of organic solvents. Scand J Work Environ Health 1980 : 6 : 19 32.
3. Pierce C H, Dills R L, Morgan M S et al. Biological monitoring of controlled toluene exposure. Int Arch Occup Environ Health 1998 : 71 : 433 44.
4. Jacobson G A, McLean S. Biological monitoring of low level occupational xylene exposure and the role of recent exposure. Ann Occup Hyg 2003 : 47 : 331 336.
5. Ogata M, Numano T, Hosokawa M, Michitsui H. Large-scale biological monitoring in Japan. Sci Total Environ 1997 : 199 : 197 204.
6. Boman A, Maibach H I. Percutaneous absorption of organic solvents. Int J Occup Environ Health 2000 : 6 : 93 95.
7. Scott R C, Dugard P H. A model for quantifying absorption through abnormal skin. J Invest Dermatol 1986 : 86 : 208 212.
8. Coenraads P J, Diepgen T L. Problems with trials and intervention studies on barrier creams and emollients at the workplace. Int Arch Occup Environ Health 2003 : 76 : 362 366.
9. Funke U, Diepen T L, Fartasch M. Risk-group-related prevention of hand eczema at the workplace. Curr Probl Dermatol 1996 : 25 : 123 132.
10. Meding B. Prevention of hand eczema in atopics. Curr Probl Dermatol 1996 : 25 : 116 122.
11. Coenraads P J, Diepgen T L. Risk for hand eczema in employees with past or present atopic dermatitis. Int Arch Occup Environ Health 1998 : 71 : 7 13.
12. Palmer C N, Irvine A D, Terron-Kwiatkowski A et al. Common loss-of-function variants of the epidermal barrier protein fillagrin are a major predisposing factor of atopic dermatitis. Nat Genet 2006 : 38 : 441 446.
13. Berndt U, Wigger-Alberti W, Gabard B, Elsner P. Efficacy of a barrier cream and its vehicle as protective measures against occupational irritant contact dermatitis. Contact Dermatitis 2000 : 42 : 77 80.
14. Nishijima T, Tokura Y, Imokawa G, Seo N, Furukawa F, Takigawa M. Altered permeability and disordered cutaneous immunoregulatory function in mice with acute barrier disruption. J Invest Dermatol 1997 : 109 : 175 182.